Photo taken from NCI CTEP Clinical Research/X
May 17, 2024, 17:35
NCI CTEP Clinical Research – Newly Activated NCTN Esophageal Cancer Gastroesophageal Cancer Trial
NCI CTEP Clinical Research shared a poston X:
“Newly Activated NCTN Esophageal Cancer Gastroesophageal Cancer Trial: (S2303) Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, The PARAMMUNE Trial, led by Dr. Saeed, UPMC Hillman Cancer Center, SWOG.”